ngs
with the Securities and Exchange Commission.
ADVANCED LIFE SCIENCES HOLDINGS, INC. AND SUBSIDIARY
(A Development Stage Company)
September 30, December 31,
CONSOLIDATED BALANCE SHEETS 2008 2007
(Unaudited)
ASSETS
CURRENT ASSETS:
Cash and cash equivalents $7,766,597 $18,324,991
Grant receivable 32,006 -
Prepaid insurance 329,363 251,493
Prepaid clinical trial expenses - 926,168
Other prepaid expenses and deposits 211,874 140,359
Total current assets 8,339,840 19,643,011
PROPERTY AND EQUIPMENT:
Furniture and fixtures 237,907 221,417
Laboratory equipment 159,186 159,186
Computer software and equipment 253,851 242,707
Leasehold improvements 502,798 177,253
Total property and equipment - at cost 1,153,742 800,563
Less accumulated depreciation (717,249) (542,032)
Property and equipment - net 436,493 258,531
OTHER ASSETS:
Deferred financing costs 361,250 -
Other long-term assets 10,000 10,000
Total other assets 371,250 10,000
TOTAL ASSETS $9,147,583 $19,911,542
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
CURRENT LIABILITIES:
Accounts payable $273,140 $2,685,751
Accrued milestone payable 10,000,000 -
Accrue
'/>"/>
SOURCE Advanced Life Sciences Holdings, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 Related biology technology :1.
Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients2.
Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter3.
Advanced Cell Technology Announces Proposed Financing4.
YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER5.
Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry6.
Advanced Life Sciences to Present at 2007 UBS Global Life Sciences Conference7.
CeloNova BioSciences Announces Worlds First Line of Fully Color-Coded Embolic Particles at CIRSE: Embozene(TM) Color-Advanced Microspheres8.
Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology9.
Advanced Bionics Deploys CEVA-TeakLite(TM) DSP Core to Enhance Its Harmony(TM) HiResolution(R) Bionic Ear System10.
NIH Announces Advanced Cell Technologys Single Cell Embryo Biopsy Technique as a Means to Derive Embryonic Stem Cells to be Considered for Federal Funding11.
Cell Therapeutics, Inc. (CTI) Receives SPA Approval from FDA and Launches Gender-Specific Phase III Trial for Advanced Non-Small Cell Lung Cancer